Education
About Us
Working with TipRanks
Follow Us
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990)
:6990
Earnings Data
Report Date
Mar 30, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-1.12Last Year’s EPS
-2.65Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) Earnings, Revenues Date & History
HK:6990 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:6990 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 18, 2025 | HK$434.00 | HK$446.80 | +2.95% |
Mar 24, 2025 | HK$260.00 | HK$260.60 | +0.23% |
Aug 19, 2024 | HK$161.00 | HK$169.40 | +5.22% |
Mar 25, 2024 | HK$163.80 | HK$171.50 | +4.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) report earnings?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) is schdueled to report earning on Mar 30, 2026, TBA (Confirmed).
What is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) earnings time?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) earnings time is at Mar 30, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H stock?
The P/E ratio of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H is N/A.
What is HK:6990 EPS forecast?
HK:6990 EPS forecast for the fiscal quarter 2025 (Q4) is -1.12.